ZEVRA THERAPEUTICS, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Zevra Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2014 to Q3 2024.
  • Zevra Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $6.14M, a 342% increase year-over-year.
  • Zevra Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $13.8M, a 241% increase year-over-year.
  • Zevra Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $5.95M, a 38.7% increase from 2022.
  • Zevra Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $4.29M, a 76.3% increase from 2021.
  • Zevra Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.44M, a 2.21% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $13.8M $6.14M +$4.75M +342% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $9.01M $2.63M +$1.53M +139% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $7.48M $2.12M +$1.53M +259% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $5.95M $2.87M +$1.92M +201% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $4.04M $1.39M +$476K +52.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $3.56M $1.1M -$407K -27% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $3.97M $591K -$327K -35.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $4.29M $955K +$132K +16% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $4.16M $911K +$291K +46.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $3.87M $1.51M +$1.19M +375% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $2.68M $918K +$243K +36% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $2.44M $823K +$366K +80.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-07
Q3 2021 $2.07M $620K +$235K +61% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $1.84M $318K -$302K -48.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $2.14M $675K -$354K -34.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $2.49M $457K -$289K -38.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $2.78M $385K -$672K -63.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $3.45M $620K -$697K -52.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $4.15M $1.03M -$261K -20.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $4.41M $746K -$502K -40.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-12
Q3 2019 $4.91M $1.06M -$1.53M -59.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-30
Q2 2019 $6.44M $1.32M -$63K -4.57% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $6.5M $1.29M +$9K +0.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 $6.5M $1.25M +$98K +8.52% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-28
Q3 2018 $6.4M $2.59M +$1.43M +123% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $4.97M $1.38M +$215K +18.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 $4.75M $1.28M +$192K +17.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 $4.56M $1.15M +$108K +10.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-01
Q3 2017 $4.45M $1.16M -$2.12M -64.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $6.58M $1.17M -$92K -7.32% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 $6.67M $1.09M +$67K +6.56% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 $6.6M $1.04M +$129K +14.1% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-30
Q3 2016 $6.47M $3.28M +$2.79M +566% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $3.68M $1.26M +$384K +44% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 $3.3M $1.02M +$931K +1023% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-22
Q4 2015 $2.37M $913K +$869K +1975% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-30
Q3 2015 $1.5M $492K +$440K +846% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $1.06M $873K +$781K +849% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 $279K $91K +$65K +250% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 $214K $44K Oct 1, 2014 Dec 31, 2014 10-K 2017-03-10
Q3 2014 $52K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 $92K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 $26K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.